about
Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenc...
Read More
116.64
0.46
(0.40%)
200.1K
XNYS Volume
XNYS 24 Dec, 2025 4:30 PM (EST)
Low Financial Strength
Expensive Valuation
Technically Moderately Bullish
Momentum Trap
These stocks have weak financials and expensive valuation. Buying interest may quickly dissipate. Investors should exercise caution
View Similar
Embed DVM
Glaukos Corp Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..